Pursuant to SEBI Circular - SEBI/ HO/ DDHS/CIR/ P/ 2018/ 144 dated November 26, 2018, Welcure Drugs & Pharmaceuticals has informed that it enclosed Annual Disclosure for the Financial Year 2021-22 as ‘Annexure B2’. It is informed that there was no incremental borrowing applicable to the company during the financial year 2021-22 as per explanation provided in the aforesaid circular; therefore, the said circular is not applicable on the company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 220.70 |
| Adani Enterprises | 2300.50 |
| Amrapali Industries | 17.45 |
| Rashi Peripheral | 475.55 |
| PDS | 285.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: